These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33426833)

  • 61. Evaluation of 2 novel devices for calculation of fluid requirements in pediatric burns.
    Dingley J; Cromey C; Bodger O; Williams D
    Ann Plast Surg; 2015 Jun; 74(6):658-64. PubMed ID: 25954841
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrospective survey of compounded medications for children in Japan.
    Saito J; Akabane M; Ishikawa Y; Iwahashi K; Nakamura H; Yamatani A
    Eur J Pharm Biopharm; 2020 Oct; 155():122-127. PubMed ID: 32853693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of a dosing device for individualized dosing of orodispersible warfarin films.
    Niese S; Breitkreutz J; Quodbach J
    Int J Pharm; 2019 Apr; 561():314-323. PubMed ID: 30877029
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
    Weidle PJ; Abrams EJ; Gvetadze R; Rivadeneira E; Kline MW
    Pediatr Infect Dis J; 2006 Jan; 25(1):59-64. PubMed ID: 16395105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation.
    Park SJ; Thapa P; Seo HJ; Park ES; Hoon Jeong S
    Int J Pharm; 2018 Oct; 549(1-2):388-396. PubMed ID: 30107219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aerosol therapy in children: challenges and solutions.
    Ari A; Fink JB
    Expert Rev Respir Med; 2013 Dec; 7(6):665-72. PubMed ID: 24224509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 3D Printing Technologies: Recent Development and Emerging Applications in Various Drug Delivery Systems.
    Jacob S; Nair AB; Patel V; Shah J
    AAPS PharmSciTech; 2020 Aug; 21(6):220. PubMed ID: 32748243
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Critical challenges to the design of drug-eluting medical devices.
    Luk A; Junnarkar G
    Ther Deliv; 2013 Apr; 4(4):471-7. PubMed ID: 23557288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modeling the physiological factors that affect drug delivery from a nipple shield delivery system to breastfeeding infants.
    Gerrard SE; Orlu-Gul M; Tuleu C; Slater NK
    J Pharm Sci; 2013 Oct; 102(10):3773-83. PubMed ID: 23934768
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Delivery of inhaled drugs for infants and small children: a commentary on present and future needs.
    Fink JB
    Clin Ther; 2012 Nov; 34(11):S36-45. PubMed ID: 23149011
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Hosseini S; Wei X; Wilkins JV; Fergusson CP; Mohammadi R; Vorona G; Golshahi L
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):374-385. PubMed ID: 31464547
    [No Abstract]   [Full Text] [Related]  

  • 73. Advances in drug delivery systems: Work in progress still needed?
    Laffleur F; Keckeis V
    Int J Pharm; 2020 Nov; 590():119912. PubMed ID: 32971178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Electronically enabled drug-delivery devices: are they part of the future?
    Fry A
    Ther Deliv; 2012 Jul; 3(7):805-7. PubMed ID: 22900463
    [No Abstract]   [Full Text] [Related]  

  • 75. Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.
    Feng J; Markwalter CE; Tian C; Armstrong M; Prud'homme RK
    J Transl Med; 2019 Jun; 17(1):200. PubMed ID: 31200738
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.
    Kovarik JM; Noe A; Berthier S; McMahon L; Langholff WK; Marion AS; Hoyer PF; Ettenger R; Rordorf C
    J Clin Pharmacol; 2003 Feb; 43(2):141-7. PubMed ID: 12616666
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.
    Rebouh S; Lefnaoui S; Bouhedda M; Yahoum MM; Hanini S
    Drug Deliv Transl Res; 2019 Feb; 9(1):162-177. PubMed ID: 30341764
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
    Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
    Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How to select the initial dose for a pediatric study?
    Ye J; Bi Y; Ting N
    J Biopharm Stat; 2023 Nov; 33(6):844-858. PubMed ID: 36476267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.